Uncategorized Archives - Page 213 of 1029

TuesdayFeb 27, 2024 12:00 pm

Astiva Health Inc. Championing Culturally Sensitive Healthcare for Aging Asian American Population

By 2060, the older Asian population in the U.S. is expected to reach 8.5 million, making up 9% of the country's elderly demographic, signaling a significant increase from 4% in 2014 Astiva Health is leading the charge in creating essential healthcare solutions tailored for this expanding demographic, demonstrating a deep understanding of their unique healthcare needs Astiva Health has introduced groundbreaking programs, including language-specific healthcare services and wellness initiatives, specifically designed for the diverse aging Asian American community Astiva Health is working serve the Asian American community, which is undergoing a considerable demographic shift, with a growing segment of the…

TuesdayFeb 27, 2024 11:15 am

Astrotech Corp. (NASDAQ: ASTC) Reports 512% Jump in YTD Revenue

Astrotech reported financial results for the quarter ended December 31, 2023, recording year-to-date revenue of $1,540,000 The company attributed the growth to the successful fulfillment of two significant purchase orders for the TRACER 1000(TM), the world’s first mass spectrometer-based explosive trace detectors (“ETD”), to customers in Romania Astrotech is focused on commercializing its innovative platform mass spectrometry technology through its wholly owned subsidiaries 1st Detect Corp., AgLAB Inc., Pro-Control Inc., and BreathTech Corp. The company and its subsidiaries are positioned to capitalize on burgeoning markets, including the global mass spectrometry market, expected to grow from an estimated $6.77 billion in…

TuesdayFeb 27, 2024 10:30 am

Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023

Sigyn's common stock, temporarily trading under the ticker symbol "SIGYD", is set to revert back to its historic symbol "SIGY" on February 29, 2024. The company, as part of its 2023 Year-End Report, summarized its development of medical technologies that target to overcome clearly defined limitations in global health. During 2023, Sigyn expanded its line-up of medical technologies designed to enhance the benefit of cancer therapies. The company’s cancer treatment pipeline now includes ImmunePrep(TM), ChemoPrep(TM), and ChemoPure(TM). The company believes the successful clinical advancement of Sigyn Therapy(TM) to treat pathogen-associated conditions beyond the reach of drugs, may offer a…

TuesdayFeb 27, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Closing of $3.6 Million Registered Direct Offering

Lexaria, a global innovator in drug delivery platforms, just announced $3.6 million in gross proceeds from its registered direct offering priced at the market The proceeds will go to critical R&D studies, patent, and legal costs, as well as general working capital purposes This is timely, given Lexaria’s resolve to double down on GLP-1 investigations for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that the registered direct offering for the purchase and sale of 1,558,443 shares of common stock at a purchase price of $2.31 – at the market under…

TuesdayFeb 27, 2024 9:00 am

Correlate Energy Corp. (CIPI) Partners With Carbonsight to Empower Businesses for Easier Transition to Low-Carbon Future

Correlate Energy, a publicly traded distributed energy solutions company, just announced its strategic partnership with Carbonsight, an online decarbonization planning tool With the partnership, Correlate will empower building portfolio owners with the tools and resources that allow them to make easier informed decisions toward decarbonization Move also complements Carbonsight’s mission of providing businesses with financially viable and environmentally sustainable solutions Correlate Energy (OTCQB: CIPI), a publicly traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation, just announced its strategic partnership with Carbonsight (by Autocase). This move brings together Carbonsight’s cutting-edge decarbonization planning software and Correlate’s…

MondayFeb 26, 2024 11:15 am

Companies Brace for New Wave of Activist Investing in 2024

Activist investors target underperforming companies with an eye toward implementing agendas to maximize shareholder value Efforts by the SEC to limit activist interventions include proposals to shorten Schedule 13 filing deadlines, mandate amendments within a day of significant changes, and prevent shareholders from interfering with a company's pro-ESG initiatives Activist investors tackle ongoing challenges by staying on top of emerging trends, adopting best practices, and forming strategic alliances DealFlow Events presents an unparalleled networking and learning opportunity: The Activist Investor Conference on March 21, 2024, in New York City Like all DealFlow events, this conference promises to deliver. The event…

MondayFeb 26, 2024 10:30 am

Quant Strats Conference 2024 To Discuss The Next Source Of Alpha

Quant Strats invites thought leaders, c-suite representatives, and executives from all over the globe, for a flourishing debate and discussion on the key trends and changes in the industry, with a specific focus on real-life applications. The Quant Strats Conference, taking place March 12th, 2024, is the leading event for quantitative thought leaders, where you can network with a crowd of over 300 quant leaders to learn the latest market dynamics. Connect with over 50 speakers from reputed entities such as Goldman Sachs, Robeco, Point72, ADIA, and many more. The Quant Strats summit provides a phenomenal platform for industry representatives…

MondayFeb 26, 2024 9:45 am

Amid Signs of New Real Estate Interest, Diamond Lake Minerals Inc. (DLMI) Builds Case for Fractional Investment Through STOs

Some high-profile investors and street-level market watchers are expressing faith that the real estate market is rebounding from last year’s slump, and are loading their money into key properties they believe have serious growth potential Utah-based Diamond Lake Minerals Inc. is creating a “powerful parent umbrella company” that pairs quality real world assets, such as real estate, with a digital “STO” asset, using the pairing as a means of inspiring confidence among those wary of involvement in the digital sector DLMI has teamed with U.S. Securities and Exchange Commission (“SEC”)-registered digital asset exchange INX to offer desired security in terms…

MondayFeb 26, 2024 9:00 am

GEMXX Corp. (GEMZ) Gets Significant Boost for Achieving 2024 Gold, Ammolite Jewelry Goals

Las Vegas-based mine-to-jewelry maker GEMXX Corporation is reporting a 600 percent YOY jump in product delivery values for the month of January The company produces iridescent Ammolite jewelry that it obtains from its own gem mines in Alberta and gold mines in British Columbia, controlling each step in its production chain with no long-term debt GEMXX entered the gold market during the past year, enjoying the precious metal’s stability and record prices amid outside economic fluctuations GEMXX is working to improve its valuation, anticipating S-K 1300 technical reports on four assets will further improve the company’s balance sheet North American…

FridayFeb 23, 2024 10:30 am

Sigyn Therapeutics Inc. (SIGYD) CEO Discusses Opportunities to Treat Cancer and Drug-Resistant Pathogens in Letter to Shareholders

Sigyn Therapeutics Chairman and CEO James A. Joyce recently provided a letter to shareholders that discussed the company’s therapeutic opportunities, challenges, and decision-making processes The letter overviewed the company’s candidate technologies to enhance the performance of cancer therapies (ImmunePrep(TM), ChemoPrep(TM), and ChemoPure(TM)), and provided an update on Sigyn Therapy(TM), an extracorporeal drug purification technology to address pathogen-associated conditions that are beyond the reach of drugs James A. Joyce, the Chairman and CEO of development-stage medical technology company Sigyn Therapeutics (OTCQB: SIGYD, SIGY), recently discussed the company’s opportunities, challenges, and decision-making processes in a letter to shareholders (https://nnw.fm/fzlAw). The company is…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Uncategorized